<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An elevated plasma fibrinogen level is a risk factor for thrombotic <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, but which of fibrinogen's functions is responsible for the increased risk is unknown </plain></SENT>
<SENT sid="1" pm="."><plain>To define better the contribution of fibrinogen to large vessel <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation, we studied carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> in <z:mp ids='MP_0002169'>wild-type</z:mp> mice, mice lacking fibrinogen (fbg-/-), mice treated with 7E9 (a blocking antibody to the fibrinogen gamma-chain C-terminus), and mice expressing a mutant fibrinogen (gamma delta 5) that lacks the gamma-chain platelet-binding motif QADGV </plain></SENT>
<SENT sid="2" pm="."><plain>In control mice, <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation resulted in occlusion in 8 +/- 2 minutes (mean +/- SD) </plain></SENT>
<SENT sid="3" pm="."><plain>In fbg-/- mice, <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> grew to large sizes, but then they abruptly embolized, confirming previous observations by others in an arteriolar <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> model </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, mice treated with 7E9 and gamma delta 5 mice developed only small, nonoclusive mural <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> and embolization was limited </plain></SENT>
<SENT sid="5" pm="."><plain>These findings reveal that a fibrinogen antibody, 7E9, or a fibrinogen mutant retaining clotting function, can limit <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation more effectively than the complete absence of fibrinogen </plain></SENT>
<SENT sid="6" pm="."><plain>We hypothesize that the smaller <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in these animals result from the ability of fibrin to bind and sequester thrombin and/or the ability of the altered fibrinogen molecules, which cannot recruit platelets, to bind to and passivate the surface </plain></SENT>
</text></document>